Breast implant technology is changing fast, and soon implants themselves may be a thing of the past. Right now there is a breast augmentation solution available that is narly instant and doesn't require surgery or a long recovery period.
Have you heard of dermal fillers? These materials are gel-like compounds that can be injected into the body. They increase the volume of the area they're injected into and are both stable and harmless in the body. Restylane and Hylaform are types of dermal fillers
Swedish scientists have developed a dermal filler called Macrolane (made by the same company that makes Restylane) specifically for breast augmentation. Made of stabilized hyaluronic acid (similarly to Hylaform), Macrolane is a soft gel-like substance that can be used to correct misshapen breast implants, contour and even add bulk to breasts. This procedure is not permenant - all dermal fillers are eventually absorbed and metabolized by the body. One round of Macrolane breast augmentation should last from 1-2 years.
Macrolane is composed of hyaluronic acid but in larger particles than those found in Restylane. This makes it more suitable for larger jobs, and also means the body absorbs it more slowly.
Using dermal fillers for breast augmentation is an out-patient procedure. After applying a local anesthetic, the doctor injects the chosen substance into the patient and that's pretty much it. The entire procedure lasts less than two hours. Because it's non-surgical, there are none of the risks of full anesthesia, nor of complications arising from surgery. Recovery time is almost zero. In short, nearly all of the features of Macrolane make this superior choice over surgery for breast augmentation.
Here's the bad news - Macrolane is not currently available in the United States. The Macrolane breast augmentation procedure is being done in France, where it seems to be meeting with general approval.
Maybe soon we will have instant-gratification non-surgical breast augmentation without the discomfort and expense of surgery.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment